Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Recombinant human endostatin continuous infusion plus chemotherapy in advanced malignant tumors
ChiCTR-OPN-17010673Phase 4Recruiting
- Sponsor
- The First Affiliated Hospital of Wannan Medical College
- Start
- Feb 2017
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of endostar in Non-hematologic malignancy, sponsored by The First Affiliated Hospital of Wannan Medical College. Primary endpoints: Time to progression (TTP), Objective response rate (ORR) and 1 more. Started Feb 2017; status: recruiting.
02
Drugs
endostar
03
Conditions
Non-hematologic malignancy
Beyond the preview
Go deeper on ChiCTR-OPN-17010673.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OPN-17010673.